Serum and urinary myoglobin following an aborted malignant hyperthermia reaction

Anaesthesia

Volumn 51, Issue 10, 1996, Pages 958-961

  Laurence, A S ^a   Vanner, G K ^a   Collins, W ^a   Hopkins, P M ^b  

^a ROYAL PRESTON HOSPITAL   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Complications; malignant hyperthermia; Enzymes; creatine kinase; Muscle, skeletal; injury, myoglobin; Neuromuscular relaxants; suxamethonium

Indexed keywords

CREATINE KINASE; DANTROLENE; MYOGLOBIN; RINGER LACTATE SOLUTION; SUXAMETHONIUM; THIOPENTAL;

ADOLESCENT; ARTICLE; BLOOD LEVEL; CASE REPORT; CREATINE KINASE BLOOD LEVEL; DISEASE PREDISPOSITION; EAR RECONSTRUCTION; HUMAN; JAW; MALE; MALIGNANT HYPERTHERMIA; MUSCLE SPASM; PERFUSION; TACHYCARDIA; URINE LEVEL;

EID: 0029812143     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2044.1996.tb14965.x     Document Type: Article

References (29)

1. ELLIS FR, HALSALL PJ, HARRIMAN DGF. The work of the Leeds Malignant hyperpyrexia unit. 1971-84. Anaesthesia 1986; 41: 809-15.
2. ELLIS FR, HALSALL PJ. Suxamethonium spasm. A differential diagnostic conundrum. British Journal of Anaesthesia 1984; 56: 381-3.
3. LARACH MG, ROSENBERG H, LARACH DR, BROENNLE AM. Prediction of malignant hyperthermia susceptibility by clinical signs. Anesthesiology 1987; 66: 547-50.
4. SCHWARTZ LK, ROCKOFF MA, KOKA BV. Masseter spasm with anesthesia: incidence and implications. Anesthesiology 1984; 61: 772-5.
5. CARROLL JB. Increased incidence of masseter spasm in children with strabismus anaesthetized with halothane and succinylcholme. Anesthesiology 1987; 67: 559-61.
6. LEARY NP, ELLIS FR. Masseteric spasm as a normal response to suxamethonium. British Journal of Anaesthesia 1990; 64: 488-92.
7. VAN DER SPEK AFL, REYNOLDS PI, FANG WB, ASHTONMILLER JA, STOHLER CS, SCHORK MA. Changes in resistance to mouth opening induced by depolarising and non-depolarising neuromuscular relaxants. British Journal of Anaesthesia 1990; 64: 21-7.
8. STONE MJ, WILLERSON JT, GOMEZ-SANCHEZ CE, WATERMAN MR. Radioimmunoassay of myoglobin in human serum. Results in patients with acute myocardial infarction. Journal of Clinical Investigation 1975; 56: 1334-9.
9. ROXIN L-E, VENGE P, FRIMAN G, HALLGREN R. Radioimmunoassays of human myoglobin in serum and urine. Scandinavian Journal of Clinical and Laboratory Investigation 1979; 39: 37-46.
10. FEINFELD DA, CHENG JT, BEYSOLOW TD, BRISCOE AM. A prospective study of urine and serum myoglobin levels in patients with acute rhabdomyolysis. Clinical Nephrology 1992; 38: 193-5.
11. WIGHT JP, LAURENCE S, HOLT S, FORREST ARW. Rhabdomyolysis with hyperkalaemia after aminophylline overdose. Medicine Science and the Law 1987; 27: 103-5.
12. LAURENCE AS. Serum myoglobin release following suxamethonium administration to children. European Journal of Anaesthesiology 1988; 5: 31-8.
13. LAURENCE AS. Serum myoglobin and creatinie kinase concentrations following surgery. British Journal of Anaesthesia 1987; 59: 939 p.
14. REICHLIN M, VISCO JP, KLOCHE FJ. Radioimmunoassay for human myoglobin. Initial experience in patients with coronary heart disease. Circulation 1978; 57: 52-6.
15. LAURENCE AS, NORRIS SH. Serum myoglobin as an indication of tourniquet muscle damage. European Journal of Anaesthesiology 1988; 5: 143-50.
16. WAKABAYASHI Y, KIKUNO T, OHWADA T, KIKAWADA R. Rapid fall in blood myoglobin in massive rhabdomyolysis and acute renal failure. Intensive Care Medicine 1994; 20: 109-12.
17. KAGEN LJ, CHRISTIAN CL. Immunologic measurements of myoglobin in human adult and fetal skeletal muscle. American Journal of Physiology 1966; 211: 656-60.
18. KOSKELO P, KEKKI M, WAGNER O. Kinetic behaviour of 131-1 labelled myoglobin in human beings. Clinical Chemistry Acta 1967; 17: 339-47.
19. BLOHMER A, KARSUNKY K-P, METZ J, TAUGNER R. Zum Schicksal, vor allem zur niererenausscheidung von exogenem hamoglobin und myoglobin bei der ratte. (Exogenous haemoglobin and myoglobin in rats, with special reference to renal excretion.) Zeitschrift fur die Gesamte Experimentelle Medizin Einsphlinislich Chirurgie 1971; 155: 112-7.
20. ANDERSON WA. The use of exogenous myoglobin as an ultrastructural tracer. Reabsorption and translocation of protein by the renal tubule. Journal of Histochemistry and Cytochemistry 1972; 20: 672-84.
21. HALSALL PJ, CAIN PA, ELLIS FR. Retrospective analysis of anaesthetics received by patients before susceptibility to malignant hyperpyrexia was recognized. British Journal of Anaesthesia 1979; 51: 949-54.
22. VAS DER SPEK AFL, FANG WB, ASHTON-MILLER JA, STOHLER CS, CARLSON DS, SCHORK MA. The effect of succinylcholine on mouth opening. Anesthesiology 1987; 67: 459-65.
23. LITTLEFORD JA, PATEL LR, BOSE D, CAMERON GB, MCKILLOP C. Masseter muscle spasm in children: implications of continuing the triggering anaesthetic. Anesthesia and Analgesia 1991; 72: 151-60.
24. 2 monitoring. Its use in the diagnosis and management of malignant hyperthermia. Anaesthesia 1984; 39: 1000-3.
25. FITZGIBBONS DC. Malignant hyperthermia following preoperative oral administration of dantrolene. Anesthesiology 1981; 54: 73-5.
26. RUHLAND G, HINKLE AJ. Malignant hyperthermia after oral and intravenous pretreatment with dantrolene in a patient susceptible to malignant hyperthermia. Anesthesiology 1984; 60: 159-60.
27. THOMAS DW, DEV VJ, WHITEHEAD MJ. Malignant hyperthermia and isoflurane. British Journal of Anaesthesia 1987; 59: 1196-8.
28. BYERS DJ, MERLIN RG. Malignant hyperthermia in a renal transplant recipient. Anesthesiology 1987; 67: 979-81.
29. ISAACS H, BARLOW MB. The genetic background to malignant hyperpyrexia revealed by serum creatine phosphokinase estimations in asymptomatic relatives. British Journal of Anaesthesia 1970; 42: 1077-84.